ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Kyverna Therapeutics Inc

Kyverna Therapeutics Inc (KYTX)

3.00
-0.11
(-3.54%)
Closed February 07 4:00PM
3.1494
0.1494
( 4.98% )
Pre Market: 8:57AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)
Total Assets 75.2M389.98M363.12M339.2M
Total Current Assets 60.66M375.49M348.82M325.37M
Cash and Equivalents 34.65M224.29M131.62M104.66M
Total Non-Current Assets 15.07M15.66M16.34M15.9M
Total Liabilities 26.02M28.99M29.61M36.49M
Total Current Liabilities 19.86M21.87M23.48M30.99M
Total Non-Current Liabilities 7.08M7.8M6.54M5.74M
Common Equity 0000
Retained Earnings -136.04M-162.74M-191.54M-226.03M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 85.49M66.92M75.2M
Total Current Assets 77.09M53.25M60.66M
Cash and Equivalents 76.07M37.74M34.65M
Total Non-Current Assets -46.25M-74M-131.4M
Total Liabilities 23.02M20.25M26.02M
Total Current Liabilities 15.93M11.95M19.86M
Total Non-Current Liabilities 7.11M9.37M7.08M
Total Equity -46.25M-74M-131.4M
Common Equity 000
Retained Earnings -46.78M-75.68M-136.04M

Your Recent History

Delayed Upgrade Clock